HC Wainwright Stock Recommendations and Price Targets

This is a list of recent ratings by HC Wainwright.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
1/19/2022
NXTP
NextPlay Technologies
Lower Price Target$1.00$3.00 ➝ $2.00BuyMedium
1/19/2022
ECOR
electroCore
Lower Price Target$1.00$3.00 ➝ $2.75BuyMedium
1/19/2022
ASM
Avino Silver & Gold Mines
Reiterated Rating$1.00 $1.25BuyN/A
1/19/2022
ASM
Avino Silver & Gold Mines
Reiterated RatingC$1.00 C$1.25BuyN/A
1/19/2022
ATAI
Atai Life Sciences
Reiterated Rating$6.00 $50.00BuyN/A
1/19/2022
VACC
Vaccitech
Reiterated Rating$10.00 $23.00BuyLow
1/19/2022
AG
First Majestic Silver
Lower Price Target$12.00$25.00 ➝ $22.50BuyHigh
1/19/2022
RVNC
Revance Therapeutics
Reiterated Rating$14.00 $18.00BuyHigh
1/19/2022
FR
First Majestic Silver
Reiterated RatingC$15.00 C$22.50BuyN/A
1/19/2022
BNTX
BioNTech
Reiterated Rating$162.00 $366.00BuyHigh
1/18/2022
BBI
Brickell Biotech
Initiated Coverage$0.00 $2.00BuyHigh
1/18/2022
RMTI
Rockwell Medical
Lower Price Target$1.00$5.00 ➝ $3.00BuyLow
1/18/2022
CTXR
Citius Pharmaceuticals
Boost Price Target$2.00$4.00 ➝ $6.00BuyMedium
1/18/2022
URE
Ur-Energy
Reiterated RatingC$2.00 C$3.00BuyN/A
1/18/2022
URGN
UroGen Pharma
Lower Price Target$7.00$50.00 ➝ $34.00BuyHigh
1/18/2022
RNLX
Renalytix AI
Initiated Coverage$15.00 $30.00BuyHigh
1/18/2022
TARO
Taro Pharmaceutical Industries
Lower Price Target$48.00$82.00 ➝ $75.00BuyHigh
1/18/2022
BIIB
Biogen
Lower Price Target$231.00$452.00 ➝ $270.00BuyLow
1/14/2022
ARTL
Artelo Biosciences
Reiterated Rating$0.00 $4.00BuyHigh
1/14/2022
ELDN
Eledon Pharmaceuticals
Reiterated Rating$4.00 $25.00BuyLow
1/14/2022
HL
Hecla Mining
Lower Price Target$6.00$7.50 ➝ $7.25BuyHigh
1/14/2022
PRPH
ProPhase Labs
Boost Price Target$7.00$12.00 ➝ $15.00BuyLow
1/14/2022
VINC
Vincerx Pharma
Initiated Coverage$7.00 $25.00BuyHigh
1/14/2022
ATRA
Atara Biotherapeutics
Reiterated Rating$15.00 $31.00BuyHigh
1/13/2022
AUMN
Golden Minerals
Reiterated Rating$0.00 $1.00BuyN/A
1/13/2022
EVFM
Evofem Biosciences
Reiterated Rating$0.00 $2.00BuyLow
1/13/2022
GLDG
GoldMining
Reiterated Rating$2.00 $6.25BuyN/A
1/13/2022
GOLD
GoldMining
Reiterated RatingC$2.00 C$6.25BuyN/A
1/13/2022
TCRR
TCR2 Therapeutics
Lower Price Target$4.00$25.00 ➝ $19.00BuyHigh
1/13/2022
CUE
Cue Biopharma
Initiated Coverage$9.00 $20.00BuyHigh
1/13/2022
IDRSF
Idorsia
UpgradeCHF 23CHF 38 ➝ CHF 41Buy ➝ BuyN/A
1/12/2022
MITO
Stealth BioTherapeutics
Reiterated Rating$1.00 $4.00BuyLow
1/12/2022
PHIO
Phio Pharmaceuticals
Reiterated Rating$1.00 $6.00BuyLow
1/12/2022
ITRG
Integra Resources
Reiterated Rating$2.00 $6.50BuyN/A
1/12/2022
MOGO
Mogo
Lower Price Target$2.00$12.00 ➝ $8.00BuyLow
1/12/2022
EXK
Endeavour Silver
Reiterated Rating$5.00 $8.00BuyLow
1/12/2022
EDR
Endeavour Silver
Reiterated RatingC$6.00 C$8.00BuyN/A
1/12/2022
BMEA
Biomea Fusion
Initiated Coverage$7.00 $13.00BuyHigh
1/12/2022
DVAX
Dynavax Technologies
Initiated Coverage$13.00 $28.00BuyMedium
1/11/2022
ACER
Acer Therapeutics
Reiterated Rating$2.00BuyLow
1/11/2022
SELB
Selecta Biosciences
Reiterated Rating$3.00 $6.00BuyLow
1/11/2022
NLTX
Neoleukin Therapeutics
Reiterated Rating$3.00 $22.00BuyHigh
1/11/2022
DYAI
Dyadic International
Reiterated Rating$4.00 $7.00BuyLow
1/11/2022
SAND
Sandstorm Gold
Boost Price Target$6.00$14.00 ➝ $15.00BuyHigh
1/11/2022
VERU
Veru
Reiterated Rating$5.00 $21.00BuyHigh
1/11/2022
SSL
Sandstorm Gold
Reiterated RatingC$8.00 C$15.00BuyN/A
1/11/2022
ALLO
Allogene Therapeutics
Reiterated Rating$12.00 $43.00BuyHigh
1/11/2022
BCRX
BioCryst Pharmaceuticals
Reiterated Rating$15.00 $30.00BuyHigh
1/11/2022
REPL
Replimune Group
Reiterated Rating$21.00 $60.00BuyLow
1/11/2022
FATE
Fate Therapeutics
Reiterated Rating$39.00 $122.00BuyHigh
1/10/2022
BNOX
Bionomics
Initiated Coverage$12.00BuyMedium
1/10/2022
XLO
Xilio Therapeutics
Initiated Coverage$14.00BuyMedium
1/10/2022
BCPC
Balchem
Boost Price Target$151.00$160.00 ➝ $170.00BuyHigh
1/7/2022
NIOBF
NioCorp Developments
Reiterated Rating$1.00 $1.40BuyLow
1/7/2022
NB
NioCorp Developments
Reiterated RatingC$1.00 C$1.40BuyN/A
1/7/2022
CANF
Can-Fite BioPharma
Reiterated Rating$1.00 $5.00BuyN/A
1/7/2022
NBIX
Neurocrine Biosciences
Reiterated Rating$73.00 $140.00BuyHigh
1/7/2022
BHVN
Biohaven Pharmaceutical
Reiterated Rating$115.00 $160.00BuyHigh
1/6/2022
NAK
Northern Dynasty Minerals
Lower Price Target$0.00$1.20 ➝ $1.10BuyN/A
1/6/2022
SPRB
Spruce Biosciences
Reiterated Rating$3.00 $20.00BuyHigh
1/6/2022
UROY
Uranium Royalty
Reiterated Rating$4.00 $5.00BuyMedium
1/6/2022
VRNA
Verona Pharma
Reiterated Rating$7.00 $25.00BuyMedium
1/6/2022
SRTS
Sensus Healthcare
Reiterated Rating$8.00 $10.00BuyLow
1/5/2022
FCUUF
Fission Uranium
Reiterated Rating$1.00 $1.60BuyHigh
1/5/2022
FCU
Fission Uranium
Reiterated RatingC$1.00 C$1.60BuyN/A
1/5/2022
PPTA
Perpetua Resources
Reiterated Rating$4.00 $12.25BuyHigh
1/5/2022
PPTA
Perpetua Resources
Reiterated RatingC$5.00 C$12.25BuyN/A
1/4/2022
MARA
Marathon Digital
Reiterated Rating$25.00BuyHigh
1/4/2022
BNTX
BioNTech
Reiterated Rating$162.00 $366.00BuyMedium
1/3/2022
RKDA
Arcadia Biosciences
Lower Price Target$1.00$7.00 ➝ $6.00BuyHigh
1/3/2022
NBSE
NeuBase Therapeutics
Reiterated Rating$2.00BuyHigh
12/31/2021
XERS
Xeris Pharmaceuticals
Boost Price Target$2.00$4.25 ➝ $5.40BuyN/A
12/29/2021
DYAI
Dyadic International
Reiterated Rating$4.00 $7.00BuyLow
12/29/2021
DVAX
Dynavax Technologies
Boost Price Target$13.00$23.00 ➝ $28.00BuyHigh
12/29/2021
NRIX
Nurix Therapeutics
Initiated Coverage$19.00 $62.00BuyMedium
12/28/2021
EQOS
Diginex
Downgrade$2.00Buy ➝ NeutralLow
12/28/2021
ALLK
Allakos
Lower Price Target$7.00$230.00 ➝ $20.00BuyLow
12/28/2021
BBIO
BridgeBio Pharma
Lower Price Target$12.00$88.00 ➝ $24.00BuyMedium
12/27/2021
OCDX
Ortho Clinical Diagnostics
Downgrade$19.00 $24.68Buy ➝ NeutralHigh
12/23/2021
OSMT
Osmotica Pharmaceuticals
Initiated Coverage$1.00 $5.00BuyHigh
12/23/2021
OTLK
Outlook Therapeutics
Reiterated Rating$1.00 $6.00BuyLow
12/23/2021
AQST
Aquestive Therapeutics
Reiterated Rating$3.00 $14.00BuyHigh
12/23/2021
ELEV
Elevation Oncology
Initiated Coverage$6.00 $12.00BuyHigh
12/23/2021
SLGL
Sol-Gel Technologies
Reiterated Rating$7.00 $20.00BuyLow
12/23/2021
CODX
Co-Diagnostics
Reiterated Rating$8.00 $15.00BuyLow
12/23/2021
IKNA
Ikena Oncology
Initiated Coverage$11.00 $25.00BuyMedium
12/22/2021
CLSD
Clearside Biomedical
Reiterated Rating$2.00 $10.00BuyLow
12/22/2021
UEC
Uranium Energy
Reiterated Rating$3.00 $7.00BuyN/A
12/22/2021
CTMX
CytomX Therapeutics
Reiterated Rating$4.00$12.00 ➝ $11.00BuyHigh
12/22/2021
GROY
Gold Royalty
Reiterated Rating$5.00 $8.25BuyN/A
12/22/2021
CMRX
Chimerix
Reiterated Rating$6.00$21.00 ➝ $24.00BuyHigh
12/22/2021
CLSK
CleanSpark
Reiterated Rating$7.00BuyHigh
12/22/2021
YMAB
Y-mAbs Therapeutics
Reiterated Rating$11.00 $68.00BuyMedium
12/22/2021
LGND
Ligand Pharmaceuticals
Reiterated Rating$116.00 $310.00BuyHigh
12/21/2021
APTO
Aptose Biosciences
Lower Price Target$1.00$14.00 ➝ $12.00BuyLow
12/21/2021
TOMZ
TOMI Environmental Solutions
Initiated Coverage$1.00 $3.50BuyHigh
12/21/2021
DBVT
DBV Technologies
Lower Price Target$2.00$14.00 ➝ $10.00BuyHigh
12/21/2021
RPHM
Reneo Pharmaceuticals
Initiated Coverage$8.00 $28.00BuyMedium
12/21/2021
TARS
Tarsus Pharmaceuticals
Initiated Coverage$19.00 $40.00BuyHigh
12/21/2021
CYTK
Cytokinetics
Boost Price Target$32.00$62.00 ➝ $69.00BuyHigh